HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhe Chen Selected Research

gastrofenzin (AN(5))

10/2019Silencing miR-21 induces polarization of astrocytes to the A2 phenotype and improves the formation of synapses by targeting glypican 6 via the signal transducer and activator of transcription-3 pathway after acute ischemic spinal cord injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhe Chen Research Topics

Disease

104Neoplasms (Cancer)
10/2022 - 09/2003
27Inflammation (Inflammations)
09/2022 - 01/2014
24Infections
12/2022 - 07/2011
15Neoplasm Metastasis (Metastasis)
01/2021 - 08/2006
15Rheumatoid Arthritis
01/2021 - 02/2009
11Spinal Cord Injuries (Spinal Cord Injury)
05/2022 - 05/2014
11Pain (Aches)
01/2022 - 01/2014
11Carcinoma (Carcinomatosis)
10/2021 - 08/2006
10Carcinogenesis
01/2022 - 08/2006
10Prostatic Neoplasms (Prostate Cancer)
06/2019 - 01/2003
9COVID-19
02/2022 - 01/2021
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2021 - 09/2010
9Liver Neoplasms (Liver Cancer)
12/2020 - 09/2003
9Hypersensitivity (Allergy)
01/2018 - 09/2013
9Nasopharyngeal Carcinoma
01/2017 - 01/2013
8Stomach Neoplasms (Stomach Cancer)
02/2022 - 11/2015
7Hepatocellular Carcinoma (Hepatoma)
10/2022 - 05/2012
7Fibrosis (Cirrhosis)
09/2022 - 11/2015
7Breast Neoplasms (Breast Cancer)
07/2022 - 01/2009
7Wounds and Injuries (Trauma)
01/2022 - 12/2015
7Lung Neoplasms (Lung Cancer)
07/2019 - 09/2012
6Drug-Related Side Effects and Adverse Reactions
09/2022 - 08/2017
6Cough
02/2022 - 04/2016
6Obesity
01/2022 - 11/2014
6Type 2 Diabetes Mellitus (MODY)
10/2021 - 10/2010
6Adenocarcinoma of Lung
09/2021 - 09/2010
5Pneumonia (Pneumonitis)
05/2022 - 01/2021
5Low Back Pain (Lumbago)
01/2022 - 06/2013
5Hypoxia (Hypoxemia)
12/2021 - 09/2011
5Necrosis
01/2021 - 04/2011
5Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2014
5Brain Neoplasms (Brain Tumor)
01/2020 - 01/2004
5Heart Failure
01/2020 - 08/2010
5Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2019 - 06/2010
5Glioma (Gliomas)
02/2018 - 01/2005
5Cholestasis
04/2016 - 01/2015
4Virus Diseases (Viral Diseases)
06/2022 - 11/2011
4Osteoporosis
05/2022 - 09/2016
4Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 08/2004
4Respiratory Sounds (Crackle)
02/2022 - 04/2016
4Hyperplasia
10/2021 - 01/2013
4Edema (Dropsy)
10/2021 - 04/2002
4Hypertension (High Blood Pressure)
01/2020 - 11/2011
4Colonic Neoplasms (Colon Cancer)
09/2019 - 01/2014
4Insulin Resistance
01/2018 - 01/2012
4Allergic Rhinitis
05/2017 - 04/2011
4Leukemia
12/2015 - 01/2009
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2015 - 09/2012
3Aplastic Anemia (Anemia, Hypoplastic)
06/2022 - 11/2011
3Human Influenza (Influenza)
05/2022 - 09/2015
3Chronic Obstructive Pulmonary Disease (COPD)
05/2022 - 01/2021
3Lymphatic Metastasis
05/2022 - 06/2014
3Thrombocytopenia (Thrombopenia)
04/2022 - 11/2011
3Fever (Fevers)
02/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2005
17Pharmaceutical PreparationsIBA
04/2022 - 11/2006
15Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2005
11MicroRNAs (MicroRNA)IBA
02/2022 - 11/2010
11Therapeutic UsesIBA
01/2021 - 08/2006
10Biological ProductsIBA
06/2022 - 02/2009
10CytokinesIBA
01/2021 - 02/2014
9Glucose (Dextrose)FDA LinkGeneric
01/2021 - 11/2011
8Long Noncoding RNAIBA
02/2022 - 01/2016
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2021 - 09/2011
8Messenger RNA (mRNA)IBA
06/2021 - 12/2012
6LipidsIBA
01/2020 - 08/2014
6cryptotanshinoneIBA
02/2017 - 09/2012
5Monoclonal AntibodiesIBA
12/2022 - 07/2010
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 09/2010
5HMGB1 Protein (HMG1)IBA
10/2021 - 11/2015
5Uric Acid (Urate)IBA
01/2021 - 01/2014
5Phosphotransferases (Kinase)IBA
01/2021 - 01/2016
5LigandsIBA
01/2020 - 01/2017
5Tumor Biomarkers (Tumor Markers)IBA
01/2020 - 01/2014
52- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
02/2017 - 09/2012
4VaccinesIBA
12/2022 - 07/2011
4Nonprescription Drugs (Patent Medicines)IBA
05/2022 - 01/2020
4CateninsIBA
05/2022 - 11/2018
4Substance PIBA
01/2022 - 04/2016
4CreatinineIBA
01/2022 - 07/2020
4CollagenIBA
10/2021 - 06/2012
4Particulate MatterIBA
06/2021 - 04/2016
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2012
4EnzymesIBA
01/2021 - 05/2008
4Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 01/2010
4tusanqiIBA
11/2019 - 12/2010
4C-Reactive ProteinIBA
01/2019 - 08/2016
4BerberineIBA
01/2019 - 10/2014
4InterleukinsIBA
01/2019 - 10/2010
4huachansuIBA
01/2016 - 09/2003
3RNA (Ribonucleic Acid)IBA
02/2022 - 11/2018
3Azithromycin (Zithromax)FDA LinkGeneric
02/2022 - 01/2021
3HomocysteineIBA
02/2022 - 12/2008

Therapy/Procedure

53Therapeutics
10/2022 - 08/2006
19Radiotherapy
05/2021 - 04/2002
18Chinese Traditional Medicine (Traditional Chinese Medicine)
05/2022 - 03/2005
12Drug Therapy (Chemotherapy)
01/2022 - 04/2012
9Brachytherapy
06/2019 - 01/2004
4Lasers (Laser)
09/2021 - 01/2005
3Transplantation
05/2022 - 08/2012